47
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Plasma Leptin Association with Body Composition and Energy Expenditure in Sickle Cell Disease

, PhD, , BS, , PhD, , PhD, FACN, , PhD & , MD
Pages 228-236 | Received 01 Oct 1999, Accepted 01 Jan 2000, Published online: 14 Jun 2013

REFERENCES

  • Bunn HF: Hemoglobin structure, function, and assembly. In Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds): “Sickle Cell Disease: Basic Principles and Clinical Practice.” Philadelphia: Lippincott-Raven, pp 19–32, 1994.
  • Glader BE: Anemia. In Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds): “Sickle Cell Disease: Basic Principles and Clinical Practice.” Philadelphia: Lippincott-Raven, pp 545–555, 1994.
  • Embury SH, Hebbel RP, Steiberg MH, Mohandas N: Pathogenesis of vasoocclusion. In Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds): “Sickle Cell Disease: Basic Principles and Clinical Practice. Philadelphia: Lippincott-Raven, pp 327–334, 1994.
  • Borel MJ, Buchowski MS, Turner EA, Goldstein RE, Flakoll PJ: Protein turnover and energy expenditure increase during exogenous nutrient availability in sickle cell disease. Am J Clin Nutr. 68: 607–614, 1998.
  • Buchowski MS, Chen KY, Sun M, Turner E: Energy balance in sickle cell disease. FASEB J 11: 2562, 1997.
  • Salman EK, Haymond MW, Bayne E: Protein and energy metabolism in prepubertal children with sickle cell anemia. Pediatr Res 40: 34–40, 1996.
  • Odonkor PO, Addae SK, Apatu RS, Yamamoto S: Basal metabolic rate and serum thyroid hormone levels in adolescent sickle cell patients. IRSC Med Sci 10: 891, 1982.
  • Badaloo A, Jackson AA, Jahoor F: Whole body protein turnover and resting metabolic rate in homozygous sickle cell disease. Clin Sci 77: 93–97, 1989.
  • Singhal A, Davies P, Sahota A, Thomas PW, Serjeant GR: Resting metabolic rate in homozygous sickle cell disease. Am J Clin Nutr 57: 32–34, 1993.
  • Singhal A, Thomas O, Cook R, Wierenga K, Serjeant G: Delayed adolescent growth in homozygous sickle cell disease. Arch Dis Child 71: 404–408, 1994.
  • Heyman MB, Vichinsky E, Katz R, Gaffield B, Hurst D, Castillo R, Chiu D, Kleman K, Ammann AJ, Thaler MM: Growth retardation in sickle-cell disease treated by nutritional support. Lancet 32: 161–166, 1985.
  • Pratt OS, Rosenstock W, Espeland MA: Influence of sickle hemoglobinopathies on growth and development. N Engl J Med 311: 7–12, 1984.
  • Stevens MCG, Maude GH, Cupidore L, Jackson H, Hayes RJ, Serjeant GR: Prepubertal growth and skeletal maturation in children with sickle cell disease. Pediatrics 78: 124–132, 1986.
  • Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269: 546–549, 1997.
  • Havel PJ: Leptin production and action: relevance to energy balance in humans. Am J Clin Nutr 67: 355–356, 1998.
  • Luke AH, Rotimi CN, Cooper RS, Long AE, Forrester TE, Wilks R, Bennett FI, Ogunbiyi O, Compton JA, Bowsher RR: Leptin and body composition of Nigerians, Jamaicans, and US Blacks. Am J Clin Nutr 67: 391–396, 1998.
  • Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1: 1155–1161, 1995.
  • Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL: Serum immunoreactive leptin concentrations in normal weight and obese humans. N Engl J Med 834: 292–295, 1995.
  • Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F, Leibel RL: Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 81: 3424–3427, 1996.
  • Piji H, Toornnvliet AC, Meinders AE: Serum leptin in normal-weight and obese humans. N Engl J Med 334: 1544, 1996.
  • Ravussin E, Pratley RE, Maffei M, Wang H, Friedman JM, Bennett PH, Bogardus C: Relatively low plasma leptin concentrations precede weight gain in Pima Indians. Nature Med 3: 238–240, 1997.
  • Rogol AD: Editorial: Leptin and Puberty. J Clin Endocrinol Metab 83: 1089–1090, 1998.
  • Boden G, Chen X, Mozzoli M, Ryan I: Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 81: 3419–3423, 1996.
  • Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS: Role of leptin in the neuroendocrine response to fasting. Nature 382: 250–252, 1997.
  • Salbe AD, Nicolson M, Ravussin E: Total energy expenditure and the level of physical activity correlate with plasma leptin concentrations in five-year old children. J Clin Invest 4: 592–595, 1997.
  • Toth M, Gottlieb S, Fisher M, Ryan AS, Nicklas BJ, Poehlman ET: Plasma leptin concentrations and energy expenditure in heart failure patients. Metabolism 46: 450–453, 1997.
  • Niskanen L, Haffner S, Karhunen LJ, Turpeinen AK, Miettinen H, Uusitupa MIJ: Serum leptin in relation to resting energy expenditure and fuel metabolism in obese subjects. Intern J Obes 21: 309–313, 1997.
  • Kennedy A, Gettys T, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT: The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 82: 1293–1300, 1997.
  • Rosenbaum M, Nicolson M, Hirsch J, Murphy E, Chu F, Leibel R: Effects of weight changes on plasma leptin concentrations and energy expenditure. J Clin Endocrinol Metab 82: 3647–3654, 1997.
  • Nagy TR, Gower BA, Shewchuk M, Goran MI: Serum leptin and energy expenditure in children. J Clin Endocrinol Metab 82: 4149–4153, 1997.
  • Stratton RJ, Dewitt O, Crowe E, Jennings G, Villar RN, Elia M: Plasma leptin, energy intake and hunger following total hip replacement surgery. Clin Sci. 93: 113–117, 1997.
  • Daniel W: Evaluation of adolescents. In Behrman R, Vaughan V (eds): “Nelson Textbook of Pediatrics.” Philadelphia: WB Saunders, pp 40–41, 1983.
  • Adams III JG: Clinical laboratory diagnosis. In Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds): “Sickle Cell Disease: Basic Principles and Clinical Practice.” Philadelphia: Lippincott-Raven, pp 457–468, 1994.
  • Serjeant GR: “Sickle Cell Disease,” 2nd ed. Oxford: Oxford University Press, 1992.
  • Webb P: 24-hour energy expenditure and the menstrual cycle. Am J Clin Nutr; 44: 616–619, 1997.
  • Solomon SJ, Kurzer MS, Calloway DH: Menstrual cycle and basal metabolic rate in women. Am J Clin Nutr 36: 611–616, 1982.
  • Sun M, Reed GW, Hill JO: Modification of a whole room indirect calorimeter for measurement of rapid changes in energy expenditure. J Appl Physiol 76: 2686–2691, 1994.
  • Sun M, Hill JO: A method for measuring mechanical work and work efficiency during human activities. J Biomechanics 26: 229–241, 1993.
  • Poehlman ET, Toth MJ: Mathematical ratios lead to spurious conclusions regarding age- and sex-related differences in resting metabolic rate. Am J Clin Nutr 61: 482–485, 1995.
  • Goldman RF, Buskirk ER: A method of underwater weighing and the determination of body density. In Brozek J, Henschel A (eds): “Techniques for Measuring Body Composition.” Washington, DC: National Academy of Sciences, pp 78–89, 1961.
  • Schutte JE, Townsend EJ, Hugg J, Shoup RF, Malina RM, Blomqvist G: Density of lean body mass is greater in blacks than in whites. J Appl Physiol 56: 1647–1649, 1997.
  • Roemmich JN, Clark PA, Berr SS, Mai V, Mantzaros CS, Flier JS, Weltman A, Rogol AD: Gender differences in leptin levels during puberty are related to the subcutaneous fat depot and sex steroids. Am J Physiol 275: E543–E551, 1998.
  • Dubuc GR, Phinney SD, Stern JS, Havel PJ: Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women. Metabolism 47: 429–434, 1998.
  • Kristensen K, Pedersen SB, Fisker S: Serum leptin levels and leptin expression in human growth hormone (GH)—deficient and healthy adults: influence of GH treatment, gender, and fasting. Metabolism 12: 1514–1519, 1998.
  • McDougald O, Hwang C, Fan H, Lane M: Regulated expression of the ob gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc Natl Acad Sci USA 92: 9034–9037, 1995.
  • Ahren B, Mansson S, Gingerich RL, Havel PJ: Regulation of plasma leptin in mice: influence of age, high-fat diet and fasting. Am J Physiol 273: R113–R120, 1997.
  • Borel MJ, Buchowski MS, Turner EA, Peeler BB, Goldstein RE, Flakoll PJ: Alterations in basal nutrient metabolism increase resting energy expenditure in sickle cell disease. Am J Physiol 274: E357–E364, 1998.
  • Weigle DS, Duell PB, Connor WE, Steiner RA, Soules MR, Kuijper JL: Effects of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab 82: 561–565, 1997.
  • Trayhurn P, Hoggard N, Mercer JG, Rayner DV: Leptin: fundamental aspects. Int J Obes (Suppl 1) 23: 22–28, 1999.
  • Friedman JF, Halaas JF: Leptin and the regulation of body weight in mammals. Nature 395: 763–770, 1998.
  • Martin LJ, Jones PJH, Considine RV, Su W, Boyd NF, Caro JF: Serum leptin levels and energy expenditure in normal weight women. Can J Physiol Pharmacol 76: 237–241, 1998.
  • Nicklas BJ, Toth MJ, Poehlman ET: Daily energy expenditure is related to plasma leptin concentrations in older African American women but not men. Diabetes 46: 1389–1392, 1997.
  • Arslanian S, Suprasongsin C, Kalhan SC, Drash AL, Brna R, Janowsky JE: Plasma leptin in children: relationship to puberty, gender, body composition, insulin sensitivity, and energy expenditure. Metabolism 47: 309–312, 1998.
  • Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstem JP: Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491–495, 1996.
  • Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzaden JG, Lee JI, Friedman JM: Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632–635, 1996.
  • Chua Jr SC, Chung WK, Wu-Peng XS: Phenotypes of mouse diabetes and rat fatty due to mutations in the ob gene leptin receptor. Science 274: 994–996, 1996.
  • Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D Jr, Woods SC, Seeley RJ, Weigle DS: Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45: 531–535, 1996.
  • Dryden S, Frankish H, Wang Q, Williams G: Neuropeptide Y and energy balance: one way ahead for the treatment of obesity? Eur J Clin Invest 24: 293–308, 1994.
  • Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A: The role of neuropeptide Y in the anti-obesity action of the gene product. Nature 377: 530–532, 1995.
  • Tatarani PA: From physiology to neuoendocrinology: a reappraisal of risk factors of body weight gain in humans. Diabetes Metab 23: 108–115, 1998.
  • Rosenbaum M, Leibel RL: The role of leptin in human physiology. NEJM 341: 913–915, 1999.
  • Wisse BE, Campfield LA, Marliss EB, Morais JA, Tenenbaum R, Gougeon R: Effect of prolonged moderate and severe energy restriction and refeeding on plasma leptin concentrations in obese women. Am J Clin Nutr 70: 321–330, 1999.
  • Sinha MK, Ohannesian JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin S, Marco C, Caro JF: Nocturnal rise of leptin in lean, obese and non-insulin dependent diabetes mellitus subjects. J Clin Invest 97: 1344–1347, 1996.
  • Nissley SP, Rechler MM: Somatomedin/insulin-like growth factor tissue receptor. Clin Endocr Metab 13: 43–46, 1994.
  • Dagogo-Jack S, Franklin SC, Vijayan A, Liu J, Askari H, Miller SB: Recombinant human insulin-like growth factor-I (IGF-I) therapy decreases plasma leptin concentration in patients with chronic renal insufficiency. Intern J Obes Metab Dis 22: 1110–1115, 1998.
  • Larsson H, Ahren B: Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women. J Clin Endocrin Metab 81: 4428–4432, 1996.
  • Papaspyrou-Rao, Schneider SH, Petersen RN, Fried SK. Dexamathasone increases leptin expression in humans in vivo. J Clin Endocrin Metab 82: 1635–1637, 1997.
  • Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetman CH, Prentice AM, Hughes IA, McCamish MA, O’Rahilly S: Effect of recombinant leptin therapy in a child with congenital leptin deficiency. N Eng J Med 341: 879–884, 1999.
  • Blum WF, Englaro P, Hanitsch S, Juul A, Hertel NT, Muller J, Skakkebaek NE, Heiman ML, Birkett M, Attanasio AM, Kiess W, Rascher W: Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab 82: 2904–2910, 1997.
  • Perry III HM, Morley JE, Horowitz M, Kaiser FE, Miller DK, Wittert G: Body composition and age in African-American and Caucasian women: relationship to plasma leptin levels. Metabolism 12: 1399–1405, 1997.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.